Why The Coming Months Could Be A “Biotech Bonanza”
“It was a difficult first half for biotech stocks, once again underscoring how conditions may seem so ideal but investment returns can still be hard to generate.”
“It was a difficult first half for biotech stocks, once again underscoring how conditions may seem so ideal but investment returns can still be hard to generate.”
“Wall Street analysts following these biotechs have high expectations for the drugs they’re developing and in one case already marketing.
If you feel like biotech stocks tend to go down right after you buy them, you’re not alone – and today’s article provides some important insights into what’s going on.
New stocks to watch in 2021.
Information collected through genetic testing business has the potential to become a powerful drug developer.
“When it comes to investing in biotech penny stocks, there are some ways to dramatically increase your chances of success and to give yourself a good chance of becoming a millionaire or even a multimillionaire in the process.”
Having posted positive returns in July in nine of the last 10 years, with an average July return of 4.8%, the medical devices and health… Read More »This Pharma Stock Has A Great Record Of Returns In July
“New therapies derived from psychedelic compounds…are offering hope, not to mention a slew of opportunities for forward-thinking investors.”
“All three picks can be volatile but very tradable and should be considered as long term holds with expectations for growth, positive clinical data or M&A.”
Tech companies involved in software, AI and e-commerce, and a medical device company that designs innovative injection technologies, are among the new stocks to watch.